Denovo Biopharma is a biotech company providing a biomarker solution to personalize drug development. It offers a platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. The technology can be used for late stage clinical drugs that have completed trials with unsatisfactory efficacy or side effects. The company aims to enable biotech and pharmaceutical companies to design new clinical trials in targeted patient population to achieve higher efficacy and/or less adverse effects.